Study of CTX-471 as a Monotherapy or in Combination With Pembrolizumab in Patients Post PD-1/PD-L1 Inhibitors in Metastatic or Locally Advanced Malignancies
Compass Therapeutics
Compass Therapeutics
Eli Lilly and Company
AstraZeneca
Pfizer
Kivu Bioscience Inc.
Amgen
Boehringer Ingelheim
Exscientia AI Limited
Seagen Inc.
Conjupro Biotherapeutics, Inc.
Boehringer Ingelheim
Moonlight Bio, Inc
Boehringer Ingelheim
Debiopharm International SA
Sotio Biotech Inc.
Novartis
Avacta Life Sciences Ltd
BeOne Medicines
Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.
Suzhou Zelgen Biopharmaceuticals Co.,Ltd
Abdera Therapeutics Inc.
NiKang Therapeutics, Inc.
MacroGenics
Amgen
SystImmune Inc.
SN BioScience
Boundless Bio, Inc.
SciTech Development, Inc.
AbbVie
Amgen
Amgen
Nerviano Medical Sciences
Boehringer Ingelheim
AbbVie
Incyte Corporation
Amgen
Janux Therapeutics
Novartis
Amgen
Sichuan Baili Pharmaceutical Co., Ltd.
NiKang Therapeutics, Inc.
Novelty Nobility, Inc.
Hangzhou DAC Biotechnology Co., Ltd.
Sichuan Baili Pharmaceutical Co., Ltd.
Bristol-Myers Squibb
Pfizer
Hoffmann-La Roche
Advenchen Laboratories, LLC
Biotroy Therapeutics
Suzhou Zelgen Biopharmaceuticals Co.,Ltd